XML 48 R37.htm IDEA: XBRL DOCUMENT v3.19.2
Investments of Operating Entities and Consolidated Funds - (Tables)
6 Months Ended
Jun. 30, 2019
Investment Holdings [Line Items]  
Marketable Securities
As of June 30, 2019 and December 31, 2018, securities owned, at fair value consisted of the following:
 
As of June 30, 2019
 
As of December 31, 2018
 
(dollars in thousands)
Common stock
$
824,881

 
$
472,299

Preferred stock
9,772

 
5,617

Warrants and rights
9,874

 
7,990

Government bonds (a)
12,892

 
13,398

Corporate bonds (d)
24,625

 
13,041

Convertible bonds (b) (c)
6,318

 
3,000

Term loan (b)
1,496

 

Trade claims (b)
10,488

 
5,543

 
$
900,346

 
$
520,888

(a)
As of June 30, 2019, maturities range from August 2019 to October 2019 with an interest rate of 0%. As of December 31, 2018, maturities ranged from April 2019 to August 2019 with an interest rate of 0%.
(b)
The Company has elected the fair value option for investments in securities of trade claims, convertible bond and term loan with a fair value of $10.5 million, $6.3 million and $1.5 million, respectively, at June 30, 2019. The Company has elected the fair value option for investments in securities of trade claims and convertible bond at a fair value of $5.5 million and $3.0 million, respectively, at December 31, 2018.
(c)
As of June 30, 2019, maturities range from April 2020 to May 2024 with an interest rate of 8%. As of December 31, 2018, the maturity was June 2020 with an interest rate of 8%.
(d)
As of June 30, 2019, maturities ranged from October 2019 to March 2038 and interest rates ranged from 4.88% to 10.75%. As of December 31, 2018, maturities ranged from April 2019 to April 2049 and interest rates ranged from 2% to 15.50%.
Schedule of Derivative Instruments
The Company's long and short exposure to derivatives is as follows:
Receivable on derivative contracts
As of June 30, 2019
 
As of December 31, 2018
 
Number of contracts / Notional Value
 
Fair value
 
Number of contracts / Notional Value
 
Fair value
 
(dollars in thousands)
Futures
$

 
$

 
$
42,288

 
$
334

Currency forwards
$
105,769

 
279

 
$
395

 
1

Swaps
$
121,469

 
9,440

 
$
13,702

 
917

Options other (a)
325,493

 
22,501

 
654,506

 
23,130

Pay to hold
$

 

 
$

 
743

 
 
 
$
32,220

 
 
 
$
25,125

(a) Includes index, equity, commodity future and cash conversion options.
Payable for derivative contracts
As of June 30, 2019
 
As of December 31, 2018
 
Number of contracts / Notional Value
 
Fair value
 
Number of contracts / Notional Value
 
Fair value
 
(dollars in thousands)
Futures
$
29,986

 
$
434

 
$

 
$

Currency forwards
$
960

 
1

 
$
96,406

 
709

Swaps
$
79,407

 
2,231

 
$
52,905

 
2,162

Options other (a)
136,420

 
19,779

 
90,730

 
13,211

 
 
 
$
22,445

 
 
 
$
16,082


(a) Includes index, equity, commodity future and cash conversion options.
The following tables present the gross and net derivative positions and the related offsetting amount, as of June 30, 2019 and December 31, 2018. This table does not include the impact of over-collateralization.
 
 
 
 
 
 
 
Gross amounts not offset in the Condensed Consolidated Statement of Financial Condition
 
 
 
Gross amounts recognized
 
Gross amounts offset on the Condensed Consolidated Statements of Financial Condition (a)
 
Net amounts included on the Condensed Consolidated Statements of Financial Condition
 
Financial instruments
 
Cash Collateral pledged (b)
 
Net amounts
 
(dollars in thousands)
As of June 30, 2019
 
 
 
 
 
 
 
 
 
 
 
Receivable on derivative contracts, at fair value
$
32,220

 
$

 
$
32,220

 
$

 
$
9,719

 
$
22,501

Payable for derivative contracts, at fair value
22,445

 

 
22,445

 

 
2,232

 
20,213

 
 
 
 
 
 
 
 
 
 
 
 
As of December 31, 2018
 
 
 
 
 
 
 
 
 
 
 
Receivable on derivative contracts, at fair value
$
25,125

 
$

 
$
25,125

 
$

 
$
1,662

 
$
23,463

Payable for derivative contracts, at fair value
16,082

 

 
16,082

 

 
2,871

 
13,211

(a)
Includes financial instruments subject to enforceable master netting provisions that are permitted to be offset to the extent an event of default has occurred.
(b)
Includes the amount of collateral held or posted.
Schedule of Other Investments
As of June 30, 2019 and December 31, 2018, other investments included the following:
 
As of June 30, 2019
 
As of December 31, 2018
 
(dollars in thousands)
Portfolio Funds, at fair value (1)
$
146,133

 
$
141,236

Equity method investments (2)
54,164

 
40,171

 
$
200,297

 
$
181,407

Schedule of Other Investments, Portfolio Funds
The Portfolio Funds, at fair value as of June 30, 2019 and December 31, 2018, included the following:
 
As of June 30, 2019
 
As of December 31, 2018
 
(dollars in thousands)
Starboard Value and Opportunity Fund LP (c)(*)
$
36,585

 
$
32,579

Formation8 Partners Fund I, L.P. (f)
33,613

 
34,099

RCG Longview Debt Fund V, L.P. (g)(*)
2,110

 
4,394

RCG Longview II LP (g) (*)
4,461

 
4,400

Cowen Healthcare Investments II LP (i) (*)
23,925

 
21,717

Eclipse Ventures Fund I, L.P. (b)
4,580

 
4,412

HealthCare Royalty Partners LP (a)(*)
1,368

 
1,833

Lagunita Biosciences, LLC (d)
5,054

 
3,833

RCG IO Renergys Sarl (i) (*)
868

 
6,369

Starboard Leaders Fund LP (e)(*)
1,454

 
1,230

Eclipse SPV I, LP (j)(*)
1,447

 
1,447

RCG Longview Equity Fund, LP (g) (*)
795

 
802

RCG Longview Debt Fund VI, LP (g) (*)
2,003

 
1,586

RCG Park Liberty GP Member LLC (g) (*)
1,102

 
1,023

HealthCare Royalty Partners II LP (a)(*)
1,653

 
1,037

RCGL PE MPA, LLC (g)(*)
646

 
618

RCG LPP2 PNW5 Co-Invest, L.P. (h)(*)
12

 
296

Other private investment (k)(*)
19,900

 
15,898

Other affiliated funds (l)(*)
4,557

 
3,663

 
$
146,133

 
$
141,236

* These Portfolio Funds are affiliates of the Company.
The Company has no unfunded commitments regarding the Portfolio Funds held by the Company except as noted in Note 17.
(a)
HealthCare Royalty Partners, L.P. and HealthCare Royalty Partners II, L.P. are private equity funds and therefore distributions will be made when cash flows are received from the underlying investments, typically on a quarterly basis.
(b)
Eclipse Ventures Fund I, L.P. is a private equity fund which invests in early stage and growth hardware companies. Distributions will be made when the underlying investments are liquidated.
(c)
Starboard Value and Opportunity Fund LP permits quarterly withdrawals upon 90 days' notice.
(d)
Lagunita Biosciences, LLC, is a healthcare investment company that creates and grows early stage companies to commercialize impactful translational science that addresses significant clinical needs, is a private equity structure and therefore distributions will be made when the underlying investments are liquidated.
(e)
Starboard Leaders Fund LP does not permit withdrawals, but instead allows terminations with respect to capital commitments upon 30 days' prior written notice at any time following the first anniversary of an investor's initial capital contribution.
(f)
Formation8 Partners Fund I, L.P. is a private equity fund which invests in early stage and growth transformational information and energy technology companies. Distributions will be made when the underlying investments are liquidated.
(g)
RCG Longview Debt Fund V, L.P., RCG Longview II LP, RCG Park Liberty GP Member LLC, RCG Longview Equity Fund, LP, RCGL PE MPA, LLC and RCG Longview Debt Fund VI, LP are real estate private equity structures. The timing of distributions depends on the nature of the underlying investments and therefore will be made either quarterly or when the underlying investments are liquidated.
(h)
RCG LPP2 PNW5 Co-Invest, L.P. is a single purpose entity formed to participate in a joint venture which acquired five multi-unit residential rental properties located in the Pacific Northwest. RCG LPP2 PNW5 Co-Invest, L.P. is a private equity structure and therefore distributions will be made when the underlying investments are liquidated.
(i)
Cowen Healthcare Investments II LP and RCG IO Renergys Sarl are private equity funds.  Distributions are made from these funds when cash flows or securities are received from the underlying investments. Investors do not have redemption rights.
(j)
Eclipse SPV I, L.P. is a co-investment vehicle organized to invest in a private company focused on software-driven automation projects.  Distributions will be made when the underlying investments are liquidated.
(k)
Other private investment represents the Company's closed end investment in a Portfolio Fund that invests in a wireless broadband communication provider in Italy.
(l)
The majority of these investment funds are affiliates of the Company or are managed by the Company and the investors can redeem from these funds as investments are liquidated.
Schedule Equity Method Investments
The following table summarizes equity method investments held by the Company:
 
 
 
 
 
As of June 30, 2019
 
As of December 31, 2018
 
(dollars in thousands)
Surf House Ocean Views Holdings, LLC
$
8,493

 
$
7,589

Starboard Value LP
27,472

 
12,699

RCG Longview Debt Fund V Partners, LLC
4,845

 
11,000

RCG Longview Management, LLC
4,407

 
1,167

RCG Longview Debt Fund VI Partners LLC
1,431

 
1,254

HealthCare Royalty GP, LLC
112

 
149

HealthCare Royalty GP II, LLC
280

 
176

RCG Longview Debt Fund IV Management, LLC
331

 
331

HealthCare Royalty GP III, LLC
2,016

 
1,573

Triartisan ES Partners LLC
1,026

 
1,500

Triartisan PFC Partners LLC
1,000

 

RCG Kennedy House, LLC
131

 
131

RCG Longview Equity Management, LLC
107

 
114

RCG LPP II GP, LLC
94

 
272

RCG Park Liberty GP Member Manager, LLC
1,248

 
1,248

Other
1,171

 
968

 
$
54,164

 
$
40,171


For the period ended June 30, 2019, one equity method investment has met the significance criteria as defined under Regulation S-X Rule 4-08(g) of the SEC guidance ("Reg S-X 4-08(g)"). As such, the Company is presenting the following summarized financial information for the significant investee for the periods ended June 30, 2019 and December 31, 2018, and three and six months ended June 30, 2019 and 2018, and such information is as follows:
 
As of June 30, 2019
 
As of December 31, 2018
 
(dollars in thousands)
 
 
Assets
 
 
 
   Cash
$
532

 
$
37

   Performance & management fee receivable
81,031

 
16,594

   Investments
4,211

 
3,599

Liabilities

 

Equity
$
85,774

 
$
20,230

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
 
(dollars in thousands)
Revenues
$
10,144

 
$
21,356

 
$
78,723

 
$
25,926

Expenses

 

 

 

Net realized and unrealized gains (losses)
102

 
191

 
662

 
242

Net Income
$
10,246

 
$
21,547

 
$
79,385

 
$
26,168

Schedule of Securities Sold, Not yet Purchased
As of June 30, 2019 and December 31, 2018, securities sold, not yet purchased, at fair value consisted of the following:
 
As of June 30, 2019
 
As of December 31, 2018
 
(dollars in thousands)
 
 
 
 
Common stock
$
409,034

 
$
194,305

Corporate bonds (a)
2,581

 
750

Government bonds (b)
4,681

 

Preferred stock
2,088

 
199

Warrants and rights
20,200

 
53

 
$
438,584

 
$
195,307

(a)
As of June 30, 2019, the maturities ranged from October 2020 to May 2029 and interest rates ranged from 1.88% to 15.50%. As of December 31, 2018, the maturities ranged from October 2022 to January 2034 and interest rates ranged from 2.25% to 9.38%.
Schedule of Assets and Associated Liabilities Accounted for as Secured Borrowings
The following tables present the contractual gross and net securities borrowing and lending agreements and the related offsetting amount as of June 30, 2019 and December 31, 2018.
 
 
 
 
 
 
 
Gross amounts not offset on the Condensed Consolidated Statement of Financial Condition
 
 
 
Gross amounts recognized
 
Gross amounts offset on the Condensed Consolidated Statements of Financial Condition (a)
 
Net amounts included on the Condensed Consolidated Statements of Financial Condition
 
Additional Amounts Available
 
Financial instruments
 
Cash Collateral pledged (b)
 
Net amounts
 
(dollars in thousands)
As of June 30, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
Securities borrowed
$
1,390,366

 
$

 
$
1,390,366

 
$

 
$
1,343,751

 
$

 
$
46,615

Securities loaned
1,492,986

 

 
1,492,986

 

 
1,445,362

 

 
47,624

 
 
 
 
 
 
 
 
 
 
 
 
 
 
As of December 31, 2018
 
 
 
 
 
 
 
 
 
 
 
 
 
Securities borrowed
$
407,795

 
$

 
$
407,795

 
$

 
$
383,593

 
$

 
$
24,202

Securities loaned
414,852

 

 
414,852

 

 
391,310

 

 
23,542

(a)
Includes financial instruments subject to enforceable master netting provisions that are permitted to be offset to the extent an event of default has occurred.
(b)
Includes the amount of cash collateral held/posted.
Investments Classified by Contractual Maturity Date
The following tables present gross obligations for securities loaned transactions by remaining contractual maturity and class of collateral pledged as of June 30, 2019 and December 31, 2018:
 
Open and Overnight
 
Up to 30 days
 
31 - 90 days
 
Greater than 90 days
 
Total
 
(dollars in thousands)
As of June 30, 2019
 
 
 
 
 
 
 
 
 
Securities loaned
 
 
 
 
 
 
 
 
 
Common stock
$
1,195,846

 
$

 
$

 
$

 
$
1,195,846

Corporate bonds
297,140

 

 

 

 
297,140

As of December 31, 2018
 
 
 
 
 
 
 
 
 
Securities loaned
 
 
 
 
 
 
 
 
 
Common stock
$
414,852

 
$

 
$

 
$

 
$
414,852

Fair Value, Concentration of Risk
 
Investment's percentage of the Company's equity
 
Issuer
 
Security Type
 
Country
 
Industry
 
Percentage of Equity
 
Market Value
 
 
 
 
 
 
 
 
 
 
 
(dollars in thousands)
As of June 30, 2019
Linkem
 
Equity
 
Italy
 
Wireless Broadband
 
8.82
%
 
$
72,036

As of December 31, 2018
Linkem
 
Equity
 
Italy
 
Wireless Broadband
 
8.36
%
 
$
66,439

Consolidated Funds  
Investment Holdings [Line Items]  
Marketable Securities
As of June 30, 2019 and 2018, securities owned, at fair value, held by the Consolidated Funds consisted of the following:
 
As of June 30, 2019
 
As of December 31, 2018
 
 
 
 
 
(dollars in thousands)
     Preferred stock
$
24,322

 
$
24,314

     Common stock
236,066

 
95,565

     Government bonds (a)

 
38,377

     Corporate bonds (b)
78,630

 
24,098

     Warrants and rights
6,274

 
5,279

 
$
345,292

 
$
187,633

(a)
As of December 31, 2018, maturities ranged from January 2019 to April 2019 and interest rates were 0%.
(b)
As of June 30,2019, maturities ranged from May 2022 to November 2025 and interest rates ranged from 4.87% to 6.50%. As of December 31, 2018, maturities ranged from August 2020 to March 2026 and interest rates ranged from 5.88% to 7.63%.
Schedule of Derivative Instruments
As of June 30, 2019 and December 31, 2018, receivable on derivative contracts, at fair value, held by the Consolidated Funds are comprised of:
 
As of June 30, 2019
 
As of December 31, 2018
 
(dollars in thousands)
Currency forwards
$
379

 
$
186

Equity swaps
1,273

 
2,477

Options
2,802

 
1,753

 
$
4,454

 
$
4,416

Payable for derivative contracts
As of June 30, 2019 and December 31, 2018, payable for derivative contracts, at fair value, held by the Consolidated Funds are comprised of:
 
As of June 30, 2019
 
As of December 31, 2018
 
(dollars in thousands)
Currency forwards
$
103

 
$
96

Equity swaps
2,405

 
713

Options
108

 
854

 
$
2,616

 
$
1,663

Schedule of Other Investments, Portfolio Funds
Investments in Portfolio Funds, at fair value
As of June 30, 2019 and December 31, 2018, investments in Portfolio Funds, at fair value, included the following:
 
As of June 30, 2019
 
As of December 31, 2018
 
(dollars in thousands)
Investments of Enterprise LP
$
99,493

 
$
97,656

Investments of Merger Fund
78,335

 
88,739

 
$
177,828

 
$
186,395

Enterprise Master  
Investment Holdings [Line Items]  
Marketable Securities
Securities owned by Enterprise Master, at fair value
 
As of December 31, 2018
 
(dollars in thousands)
Common stock
$
469

 
$
469

Schedule of Other Investments, Portfolio Funds
Portfolio Funds, owned by Enterprise Master, at fair value
 
 
As of December 31, 2018
 
Strategy
(dollars in thousands)
RCG Special Opportunities Fund, Ltd*
Multi-Strategy
$
111,548

Other Private Investments
Various
846

 
 
$
112,394

*
Affiliates of the Company.
Merger Master  
Investment Holdings [Line Items]  
Marketable Securities
Merger Master
 
As of June 30, 2019
 
As of December 31, 2018
 
(dollars in thousands)
Securities owned by Merger Master, at fair value
 
 
 
Common stock
$
324,742

 
$
162,811

Corporate bonds
70,194

 
116,488

 
$
394,936

 
$
279,299

 
 
 
 
Securities sold, not yet purchased, by Merger Master, at fair value
 
 
 
Common stock
$
111,074

 
$
9,610

 
$
111,074

 
$
9,610

Schedule of Derivative Instruments
Receivable on derivative contracts, at fair value, owned by Merger Master
 
As of June 30, 2019
 
As of December 31, 2018
 
 
 
 
Description
(dollars in thousands)
Options
$
4,291

 
$
3,450

Equity swaps
102

 
5,320

 
$
4,393

 
$
8,770

Payable for derivative contracts, at fair value, owned by Merger Master
 
As of June 30, 2019
 
As of December 31, 2018
Description
(dollars in thousands)
Options
$
194

 
$
1,430

Currency forwards
37,309

 
270

Equity swaps
347

 
28

 
$
37,850

 
$
1,728